Replies to post #42765 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Our development of ZYESAMI is based on intellectual property licensed to us by the Research Foundation of the State University of New York. We have a commercial partnership with Relief Therapeutics Holdings, SA and its wholly owned subsidiary Therametrics Discovery AG (collectively, “Relief Therapeutics”) in which we and Relief Therapeutics have agreed to share profits from ZYESAMI for certain indications, based on Relief Therapeutics’ funding of our development efforts.